Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Revenue

In the year 2023, Bolt Biotherapeutics had annual revenue of $7.88M with 37.48% growth. Revenue in the quarter ending December 31, 2023 was $2.09M with 48.05% year-over-year growth.

• Revenue (ttm): $7.88M
• Revenue Growth: +37.48%
• P/S Ratio: 5.33
• Revenue / Employee: $78,760
• Employees: 100
• Market Cap: 41.94M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.88M	2.15M	37.48%
Dec 31, 2022	5.73M	4.47M	354.68%
Dec 31, 2021	1.26M	1.03M	445.45%
Dec 31, 2020	231.00K	16.00K	7.44%
Dec 31, 2019	215.00K	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.